Investors

Is Commercial Metals' Stock a Bargain by the Numbers?

Numbers can lie -- but they're the best first step in determining whether a stock is a buy. In this series, we use some carefully chosen metrics to size up a stock's true value based on the following clues:

Does This Make Amphenol a Sell?

There's no foolproof way to know the future for Amphenol (NYSE: APH) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.

Don't Get Too Worked Up Over Ryanair Holdings' Earnings

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

Why the Earnings at Amdocs Are Outstanding

Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.

7 Reasons to Worry About Next Week

 We may be heading into a holiday-abridged trading week, but it doesn't mean that corporate earnings are going home for the holidays. In fact, stick around and you're find that more than a few companies are about to leave some serious lumps of coal in the stockings of shareholders.

 

Is Lancaster Colony Going to Burn You?

 There's no foolproof way to know the future for Lancaster Colony (Nasdaq: LANC) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.

 

Our Top Dividend Stock Idea

 Each week, Motley Fool editors cull a top stock idea from the pitches made on CAPS, the Motley Fool's 170,000-member free investing community. Want your idea considered for this series? Make a compelling pitch on CAPS with a minimum length of 400 words. Want to follow our weekly picks? Subscribe to our RSS feed or follow us on Twitter.

West Pharmaceutical Services Passes This Key Test

 There's no foolproof way to know the future for West Pharmaceutical Services (NYSE:WST) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.

 

This Week's 5 Smartest Stock Moves

 If you're feeling good about the market, you're not alone. Take my hand as we go over some of this week's more uplifting headlines.

 

Is Brady Going to Burn You?

 There's no foolproof way to know the future for Brady (NYSE: BRC) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result. Rest assured: Even if you're not monitoring these metrics, short-sellers are.

 

How to Plug the Holes in Your Portfolio

 These days, lots of financial products claim to give you complete coverage of a particular type of investment. But when you take a closer look, you might realize that you're not always getting everything you think you are.

 

Why the Earnings at Amdocs Are Outstanding

 
Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.